Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (117)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Johnson, E. M.
Right arrow Articles by Warnock, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, E. M.
Right arrow Articles by Warnock, D. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 42, 741-745, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi [In Process Citation]

EM Johnson, A Szekely and DW Warnock
Public Health Laboratory, Bristol, UK.

The in-vitro fungistatic and fungicidal activities of voriconazole were compared with those of itraconazole and amphotericin B. MICs for 110 isolates belonging to 11 species of filamentous fungi were determined by a broth microdilution adaptation of the method recommended by the National Committee for Clinical Laboratory Standards. Minimum lethal concentrations (MLCs) of the three antifungal agents were also determined. The MIC ranges of the three compounds were comparable for Aspergillus flavus, Aspergillus fumigatus, Cladophialophora bantiana and Exophiala dermatitidis. Voriconazole and itraconazole were more active than amphotericin B against Fonsecaea pedrosoi, but the two azole agents were less active against Sporothrix schenckii. Voriconazole was more active than itraconazole or amphotericin B against Scedosporium apiospermum, but less active than the other two agents against two mucoraceous moulds, Absidia corymbifera and Rhizopus arrhizus. Voriconazole and amphotericin B were more active than itraconazole against Fusarium solani. With the exception of S. apiospermum, all the moulds tested had MLC50 values of < or =2 mg/L and MLC90 values of < or =4 mg/L against amphotericin B. Voriconazole and itraconazole showed fungicidal effects against five of the 1 1 moulds tested (A. flavus, A. fumigatus, C. bantiana, E. dermatitidis and F. pedrosoi) with MLC90 values of < or =2 mg/L. In addition, voriconazole was fungicidal for Phialophora parasitica. Our results suggest that voriconazole could be effective against a wide range of mould infections in humans.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
R. Marimon, C. Serena, J. Gene, J. Cano, and J. Guarro
In Vitro Antifungal Susceptibilities of Five Species of Sporothrix
Antimicrob. Agents Chemother., February 1, 2008; 52(2): 732 - 734.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
R. Marimon, J. Cano, J. Gene, D. A. Sutton, M. Kawasaki, and J. Guarro
Sporothrix brasiliensis, S. globosa, and S. mexicana, Three New Sporothrix Species of Clinical Interest
J. Clin. Microbiol., October 1, 2007; 45(10): 3198 - 3206.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. Meletiadis, C. Antachopoulos, T. Stergiopoulou, S. Pournaras, E. Roilides, and T. J. Walsh
Differential Fungicidal Activities of Amphotericin B and Voriconazole against Aspergillus Species Determined by Microbroth Methodology
Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3329 - 3337.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
P. Lalitha, B. L. Shapiro, M. Srinivasan, N. V. Prajna, N. R. Acharya, A. W. Fothergill, J. Ruiz, J. D. Chidambaram, K. J. Maxey, K. C. Hong, et al.
Antimicrobial Susceptibility of Fusarium, Aspergillus, and Other Filamentous Fungi Isolated From Keratitis
Arch Ophthalmol, June 1, 2007; 125(6): 789 - 793.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
D. A. Enoch, H. A. Ludlam, and N. M. Brown
Invasive fungal infections: a review of epidemiology and management options.
J. Med. Microbiol., July 1, 2006; 55(Pt 7): 809 - 818.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L. Trilles, B. Fernandez-Torres, M. dos Santos Lazera, B. Wanke, A. de Oliveira Schubach, R. de Almeida Paes, I. Inza, and J. Guarro
In Vitro Antifungal Susceptibilities of Sporothrix schenckii in Two Growth Phases
Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3952 - 3954.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. Krishnan, E. K. Manavathu, and P. H. Chandrasekar
A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus
J. Antimicrob. Chemother., June 1, 2005; 55(6): 914 - 920.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
M. J. Linares, G. Charriel, F. Solis, F. Rodriguez, A. Ibarra, and M. Casal
Susceptibility of Filamentous Fungi to Voriconazole Tested by Two Microdilution Methods
J. Clin. Microbiol., January 1, 2005; 43(1): 250 - 253.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
T. P. Levin, D. E. Baty, T. Fekete, A. L. Truant, and B. Suh
Cladophialophora bantiana Brain Abscess in a Solid-Organ Transplant Recipient: Case Report and Review of the Literature
J. Clin. Microbiol., September 1, 2004; 42(9): 4374 - 4378.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. C. Serrano, M. Ramirez, D. Morilla, A. Valverde, M. Chavez, A. Espinel-Ingroff, R. Claro, A. Fernandez, C. Almeida, and E. Martin-Mazuelos
A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp.
J. Antimicrob. Chemother., May 1, 2004; 53(5): 739 - 742.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Dannaoui, J. F. G. M. Meis, D. Loebenberg, and P. E. Verweij
Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis
Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3647 - 3650.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
M. C. Serrano, D. Morilla, A. Valverde, M. Chavez, A. Espinel-Ingroff, R. Claro, M. Ramirez, and E. M. Mazuelos
Comparison of Etest with Modified Broth Microdilution Method for Testing Susceptibility of Aspergillus spp. to Voriconazole
J. Clin. Microbiol., November 1, 2003; 41(11): 5270 - 5272.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
W. J. Steinbach, W. A. Schell, J. L. Miller, and J. R. Perfect
Scedosporium prolificans Osteomyelitis in an Immunocompetent Child Treated with Voriconazole and Caspofungin, as Well as Locally Applied Polyhexamethylene Biguanide
J. Clin. Microbiol., August 1, 2003; 41(8): 3981 - 3985.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
E. Nulens, C. Eggink, A. J. M. M. Rijs, P. Wesseling, and P. E. Verweij
Keratitis Caused by Scedosporium apiospermum Successfully Treated with a Cornea Transplant and Voriconazole
J. Clin. Microbiol., May 1, 2003; 41(5): 2261 - 2264.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
J. E. Kim, S. L. Perkins, and G. J. Harris
Voriconazole Treatment of Fungal Scleritis and Epibulbar Abscess Resulting From Scleral Buckle Infection
Arch Ophthalmol, May 1, 2003; 121(5): 735 - 737.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. M Pearson, P D. Rogers, J. D Cleary, and S. W Chapman
Voriconazole: A New Triazole Antifungal Agent
Ann. Pharmacother., March 1, 2003; 37(3): 420 - 432.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
E. Dannaoui, J. Meletiadis, J. W. Mouton, J. F. G. M. Meis, P. E. Verweij, and the Eurofung Network
In vitro susceptibilities of zygomycetes to conventional and new antifungals
J. Antimicrob. Chemother., January 1, 2003; 51(1): 45 - 52.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
A. Espinel-Ingroff, V. Chaturvedi, A. Fothergill, and M. G. Rinaldi
Optimal Testing Conditions for Determining MICs and Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Uncommon Molds: NCCLS Collaborative Study
J. Clin. Microbiol., October 1, 2002; 40(10): 3776 - 3781.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
A. Espinel-Ingroff, A. Fothergill, J. Peter, M. G. Rinaldi, and T. J. Walsh
Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative Study
J. Clin. Microbiol., September 1, 2002; 40(9): 3204 - 3208.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Dannaoui, J. W. Mouton, J. F. G. M. Meis, and P. E. Verweij
Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of Zygomycosis
Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1953 - 1959.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
A. Espinel-Ingroff
In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi
J. Clin. Microbiol., March 1, 2001; 39(3): 954 - 958.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
A. Espinel-Ingroff
Germinated and Nongerminated Conidial Suspensions for Testing of Susceptibilities of Aspergillus spp. to Amphotericin B, Itraconazole, Posaconazole, Ravuconazole, and Voriconazole
Antimicrob. Agents Chemother., February 1, 2001; 45(2): 605 - 607.
[Abstract] [Full Text]

Home page
 ASH Education BookHome page
G. R. Donowitz, D. G. Maki, C. J. Crnich, P. G. Pappas, and K. V.I. Rolston
Infections in the Neutropenic Patient-- New Views of an Old Problem
Hematology, January 1, 2001; 2001(1): 113 - 139.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R.-K. Li, M. A. Ciblak, N. Nordoff, L. Pasarell, D. W. Warnock, and M. R. McGinnis
In Vitro Activities of Voriconazole, Itraconazole, and Amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum
Antimicrob. Agents Chemother., June 1, 2000; 44(6): 1734 - 1736.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
E. M. Johnson, A. Szekely, and D. W. Warnock
In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold Pathogens
Antimicrob. Agents Chemother., May 1, 1999; 43(5): 1260 - 1263.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.